ArriVent BioPharma Inc. C... (AVBP)
ArriVent BioPharma Common Stock Max Pain By Strike
AVBP trades at $19.54, 56.3% above the near-term max pain of $12.5 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$25), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
ArriVent BioPharma Common Stock Max Pain By Expiry
Max pain for AVBP shows an upward trend from 2.5 to 25, suggesting bullish positioning in longer-dated options. The 144% spread signals divergent expectations across timeframes. Levels distributed around 19.54. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12.5 | -7.04 (-36.03%) |
| Oct 17, 2025 | 22.5 | 2.96 (15.15%) |
| Jan 16, 2026 | 25 | 5.46 (27.94%) |
| Apr 17, 2026 | 2.5 | -17.04 (-87.21%) |